Exelixis Inc. Common Stock vs HSBC Holdings plc — how do they compare? Exelixis Inc. Common Stock trades at $60.07 (market cap $14.62B), while HSBC Holdings plc trades at $92.77 (market cap $311.92B). The key difference: HSBC Holdings plc is far larger — about 21.3× Exelixis Inc. Common Stock's market cap, and HSBC Holdings plc pays a 4.05% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and HSBC Holdings plc for 36 Days on average.
| EXEL | HSBC | |
|---|---|---|
Market Cap | $14.62B | $311.92B |
Volume | 2,684,957 | 3,546,658 |
Sector | Health | Financials |
52-Week High | $59.13 | $107.86 |
52-Week Low | $34.54 | $65.67 |
Typical Hold Time | 0 Days | 36 Days |
Enterprise Value | $13.95B | $222.19B |
Dividend Yield | — | 4.05% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HSBC trades at $92.80, down 0.97% with bearish technical signals. The stock shows strong profitability with 34.54% net margin and reasonable valuation at 13.23 P/E. Recent earnings were mixed with Q2 beat but Q1 miss. Analyst sentiment is cautious with 38% buy ratings. The bank is expanding in technology banking and US wealth services while restructuring European operations.
HSBC offers value with solid fundamentals but faces near-term headwinds from technical weakness and mixed earnings performance. Growth opportunities in Asian markets and wealth management balance risks from European restructuring and CFO transition in 2027.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →